AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes
Authors: Pajunen, P Syvanne, M Castro, G Nieminen, MS Taskinen, MR
Citation: P. Pajunen et al., Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes, SC CARDIOVA, 35(2), 2001, pp. 96-100
Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia
Authors: Ylitalo, K Pajukanta, P Meri, S Cantor, RM Mero-Matikainen, N Vakkilainen, J Nuotio, I Taskinen, MR
Citation: K. Ylitalo et al., Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia, ART THROM V, 21(5), 2001, pp. 838-843
Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects
Authors: Syvanne, M Pajunen, P Kahri, J Lahdenpera, S Ehnholm, C Nieminen, MS Taskinen, MR
Citation: M. Syvanne et al., Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects, CORON ART D, 12(2), 2001, pp. 99-106
Pathogenesis of dyslipidemia in type 2 diabetes
Authors: Taskinen, MR
Citation: Mr. Taskinen, Pathogenesis of dyslipidemia in type 2 diabetes, EXP CL E D, 109, 2001, pp. S180-S188
Metabolic effects of metformin in patients with impaired glucose tolerance
Authors: Lehtovirta, M Forsen, B Gullstrom, M Haggblom, M Eriksson, JG Taskinen, MR Groop, L
Citation: M. Lehtovirta et al., Metabolic effects of metformin in patients with impaired glucose tolerance, DIABET MED, 18(7), 2001, pp. 578-583
Effects of oral and transdermal estrogen replacement therapy on markers ofcoagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women
Authors: Vehkavaara, S Silveira, A Hakala-Ala-Pietila, T Virkamaki, A Hovatta, O Hamsten, A Taskinen, MR Yki-Jarvinen, H
Citation: S. Vehkavaara et al., Effects of oral and transdermal estrogen replacement therapy on markers ofcoagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women, THROMB HAEM, 85(4), 2001, pp. 619-625
Cardiovascular morbidity and mortality associated with the metabolic syndrome
Authors: Isomaa, B Almgren, P Tuomi, T Forsen, B Lahti, K Nissen, M Taskinen, MR Groop, L
Citation: B. Isomaa et al., Cardiovascular morbidity and mortality associated with the metabolic syndrome, DIABET CARE, 24(4), 2001, pp. 683-689
Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes
Authors: Chaturvedi, N Fuller, JH Taskinen, MR
Citation: N. Chaturvedi et al., Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes, DIABET CARE, 24(12), 2001, pp. 2071-2077
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Authors: Steiner, G Hamsten, A Hosking, J Stewart, D McLaughlin, P Gladstone, P Sole, M Syvanne, M Hamsten, A Camelon, K Schloegl, G Genest, J Reeves, F Savard, R Letarte, A Bellavance, N Touchette, J Latour, Y Marchand, P Rondeau, C Rivard-Gervais, N Belanger, A Hamel, D Dumas, R Sandri, M Morin, N Caponi, E Barbeau, C Gauthier, S Ooi, TC Davies, RF Braaten, JT Baker, A Favreau, C Collar, C Zinman, B Gladstone, P Aldridge, H Donat, DJ Tsui, E Barnie, A DiMonte, L MacLean, S Bond, M Camelon, K Martin, C Zawacki, R Dziuran, K Gouveia, MR Taskinen, MR Nieminen, M Nikkila, K Virtanen, K Makimattila, S Malmstrom, R Kohtamaki, H Jamsen, P Salo, A Puupponen, M Kesaniemi, A Ikaheimo, M Ukkola, O Salmela, P Savolainen, M Huikuri, H Airaksinen, J Koistinen, J Mannermaa, L Ukkola, L Ketonen, K Silaste, ML Salovaara, A Efendic, S Svane, B Hellekant, C Bavenholm, P Karlen, A Hadell, K Hamsten, A Franson, K Mohlkert, D Nordlander, R Ehrenstig, L Tan, MH Title, LM Johnstone, D Winch, S Higgins-Bowser, I Shlossberg, A Murdock, H Elliott, T Fung, A Jalbert, A Leung, S Turnbull, S Norman, E Valensi, P Farez, C Tavolaro, O Sachs, RN Sedjari, F Laakso, M Kettunen, R Eranen, J Lehto, S Raisanen, R Jantunen, A Valve, R Toivanen, A Frohlich, J Vannetta, H Bowden, F Seccombe, DW Ehnholm, C Gref, CG Ikonen, M Sundvall, J Seccombe, DW McGuinness, C Ho, A Hamilton, J Pritchard, H McLaughlin, P Gladstone, P Allard, N Bond, M Bui, S Van der Wal, H Hosking, J Davis, CE Tyroler, HA Stewart, D Curtis, RC Miles, M Khaltaev, N Sole, M Kirkeeide, R Frick, H Hata, Y Rifkind, B Zimmet, P Gent, M Schonfeld, G de Bono, D Reeves, F Carter, A Ansquer, JC Fraitag, B Guivarc'h, PH Irvine, A Jacovella, J Munoz, A Rode, H Yacine, A Asmar-Kristiansen, D Bonnefous, F Belanger, F Bond, M Brown, M DeLorme, L Galos, C Jenkins, R Lanoue, C Moussalli, R Murtomaki, E Zandomenighi, F
Citation: G. Steiner et al., Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study, LANCET, 357(9260), 2001, pp. 905-910
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment
Authors: Karpe, F Taskinen, MR Nieminen, MS Frick, MH Kesaniemi, YA Pasternack, A Hamsten, A Syvanne, M
Citation: F. Karpe et al., Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment, ATHEROSCLER, 157(1), 2001, pp. 181-187
The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes
Authors: Isomaa, B Henricsson, M Almgren, P Tuomi, T Taskinen, MR Groop, L
Citation: B. Isomaa et al., The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes, DIABETOLOG, 44(9), 2001, pp. 1148-1154
A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men
Authors: Svensson, J Bengtsson, BA Taskinen, MR Wiklund, O Johannsson, G
Citation: J. Svensson et al., A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men, GROWTH H I, 10(3), 2000, pp. 118-126
G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia
Authors: Pihlajamaki, J Karjalainen, L Karhapaa, P Vauhkonen, I Taskinen, MR Deeb, SS Laakso, M
Citation: J. Pihlajamaki et al., G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia, ART THROM V, 20(7), 2000, pp. 1789-1795
Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus
Authors: Klannemark, M Suurinkeroinen, L Orho-Melander, M Groop, L Taskinen, MR
Citation: M. Klannemark et al., Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus, DIABET MED, 17(8), 2000, pp. 599-605
Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy
Authors: Hamsten, A Syvanne, M Silveira, A Luong, LA Nieminen, MS Humphries, S Frick, MH Taskinen, MR
Citation: A. Hamsten et al., Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy, THROMB HAEM, 83(3), 2000, pp. 397-403
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes
Authors: Li, HY Groop, L Isomaa, B Tuomi, T Taskinen, MR
Citation: Hy. Li et al., Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes, DIABET CARE, 23(5), 2000, pp. 589-594
Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families
Authors: Ylitalo, K Large, V Pajukanta, P Reynisdottir, S Porkka, KVK Vakkilainen, J Nuotio, I Taskinen, MR Arner, P
Citation: K. Ylitalo et al., Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families, ATHEROSCLER, 153(2), 2000, pp. 373-381
Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease
Authors: Mero, N Malmstrom, R Steiner, G Taskinen, MR Syvanne, M
Citation: N. Mero et al., Postprandial metabolism of apolipoprotein B-48-and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease, ATHEROSCLER, 150(1), 2000, pp. 167-177
Differences in HDL-cholesterol : apoA-I plus apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
Authors: Soedamah-Muthu, SS Colhoun, HM Taskinen, MR Idzior-Walus, B Fuller, JH
Citation: Ss. Soedamah-muthu et al., Differences in HDL-cholesterol : apoA-I plus apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients, DIABETOLOG, 43(11), 2000, pp. 1353-1359
Insulin secretion and insulin sensitivity in relation to glucose tolerance- Lessons from the Botnia Study
Authors: Tripathy, D Carlsson, M Almgren, P Isomaa, B Taskinen, MR Tuomi, T Groop, LC
Citation: D. Tripathy et al., Insulin secretion and insulin sensitivity in relation to glucose tolerance- Lessons from the Botnia Study, DIABETES, 49(6), 2000, pp. 975-980
Endothelial dysfunction in men with small LDL particles
Authors: Vakkilainen, J Makimattila, S Seppala-Lindroos, A Vehkavaara, S Lahdenpera, S Groop, PH Taskinen, MR Yki-Jarvinen, H
Citation: J. Vakkilainen et al., Endothelial dysfunction in men with small LDL particles, CIRCULATION, 102(7), 2000, pp. 716-721
Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women
Authors: Vehkavaara, S Hakala-Ala-Pietila, T Virkamaki, A Bergholm, R Ehnholm, C Hovatta, O Taskinen, MR Yki-Jarvinen, H
Citation: S. Vehkavaara et al., Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women, CIRCULATION, 102(22), 2000, pp. 2687-2693
Suppression of nocturnal fatty acid concentrations by bedtime carbohydratesupplement in type 2 diabetes: effects on insulin sensitivity, lipids, andglycemic control
Authors: Axelsen, M Lonnroth, P Lenner, RA Taskinen, MR Smith, U
Citation: M. Axelsen et al., Suppression of nocturnal fatty acid concentrations by bedtime carbohydratesupplement in type 2 diabetes: effects on insulin sensitivity, lipids, andglycemic control, AM J CLIN N, 71(5), 2000, pp. 1108-1114
Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus
Authors: Pajunen, P Taskinen, MR Nieminen, MS Syvanne, M
Citation: P. Pajunen et al., Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus, AM J CARD, 86(10), 2000, pp. 1080-1085
Proceedings of a satellite symposium held during the 34th Meeting of the European Association for the Study of Diabetes, 8-12(th) September 1998, Barcelona
Authors: Taskinen, MR
Citation: Mr. Taskinen, Proceedings of a satellite symposium held during the 34th Meeting of the European Association for the Study of Diabetes, 8-12(th) September 1998, Barcelona, ACT DIABETO, 36(3), 1999, pp. A6-A6
Risultati: 1-25 | 26-44